Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Breast Cancer Female × Dexmedetomidine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 15 Breast Neoplasms 11 Brain Neoplasms 10 Agnosia 7 Neoplasms 6 Thyroid Neoplasms 4 Stomach Neoplasms 4 Delirium 4 Pituitary Neoplasms 3 Lung Neoplasms 3 Emergence Delirium 3 Chronic Pain 3 Supratentorial Neoplasms 2 Rectal Neoplasms 2 Prostatic Neoplasms 2 Pheochromocytoma 2 Pain, Intractable 2 Pain 2 Liver Neoplasms 2 Dexmedetomidine 2 Colorectal Neoplasms 2 Central Nervous System Diseases 2 Abdominal Neoplasms 2 Urinary Bladder Neoplasms 1 Spinal Cord Neoplasms 1 Sleep Initiation and Maintenance Disorders 1 Sleep Deprivation 1 Sigmoid Neoplasms 1 Seizures 1 Sedation 1

Interventions

Tamoxifen 3 pyrotinib 2 abemaciclib 2 Metformin 2 Exercise 2 Cyclophosphamide 2 Capecitabine 2 Bupivacaine 2 Aromatase Inhibitors 2 palbociclib 1 exemestane 1 durvalumab 1 darolutamide 1 Yoga 1 Waiting Lists 1 Vitamin D 1 Tumor Burden 1 Tretinoin 1 Trastuzumab 1 Tocopherols 1 Thioctic Acid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Standard of Care 1 Sodium Chloride 1 Self-Help Groups 1 Saline Solution 1 Ropivacaine 1 Radiotherapy 1 Radiofrequency Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03063073 2026-02-12

pec's

South Egypt Cancer Institute

Phase 3 Completed

Breast Cancer Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡